Children with ADHD mostly rely on medication, yet families face concerns over side effects, tolerance issues, and inconsistent long-term outcomes. Access to behavioral therapy is also limited, with long waiting times and high costs, leaving many children without timely or effective care. EYAS Focus provides a safe, non-pharmacological alternative through a smartphone-based Digital Therapeutics platform. Using only the phone’s camera, it applies advanced eye-tracking and microsaccade analysis to predict attention decline up to three minutes in advance. The system adapts training automatically, visualizing an Attention Index on a 0–100 scale and engaging children through gamified feedback with animated characters. This innovation enables children to train independently without constant supervision, while caregivers receive transparent progress reports. By combining screening, intervention, and feedback in a single device, EYAS Focus delivers accessible, personalized therapy at home, restoring children’s self-esteem and easing the emotional and financial burden on families.